|
|
|
|
||
BOAHope you're right Geri.... BofA $HZNP $141~survey 24 oculoplastic/neuro-ophthalmologists Re Tepezza. C19 omicron impact4 2Q looks small, established/high prescribers indicate stable new start outlook, most respondents see core acute TED growing, payer access stable YTD. ReitBuy~undemanding value, good r/r. |
return to message board, top of board |